Analysts’ Opinions Are Mixed on These Healthcare Stocks: Avantor (AVTR) and Veeva Systems (VEEV)
TipRanks (Wed, 1-Apr 11:10 AM ET)
Avantor Announces CFO Resignation and Interim Finance Leadership
TipRanks (Wed, 1-Apr 9:04 AM ET)
Avantor CFO R. Brent Jones to depart
Seeking Alpha News (Wed, 1-Apr 8:18 AM ET)
Avantor Announces CFO Transition
PRNewswire (Wed, 1-Apr 8:00 AM ET)
Globe Newswire (Thu, 12-Mar 10:29 AM ET)
Avantor’s 2025 Results Highlight Strategic Revival Amid Margin Pressure and Cash Flow Strength
Market Chameleon (Wed, 11-Feb 2:07 AM ET)
Avantor Reports Fourth Quarter and Full Year 2025 Results
PRNewswire (Wed, 11-Feb 6:05 AM ET)
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
PRNewswire (Wed, 28-Jan 2:42 PM ET)
Avantor to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
PRNewswire (Mon, 12-Jan 8:05 AM ET)
Avantor to Participate in 44th Annual J.P. Morgan Healthcare Conference
PRNewswire (Mon, 5-Jan 8:05 AM ET)
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Avantor trades on the NYSE stock market under the symbol AVTR.
As of April 1, 2026, AVTR stock price declined to $7.77 with 7,328,831 million shares trading.
AVTR has a beta of 1.03, meaning it tends to be more sensitive to market movements. AVTR has a correlation of 0.10 to the broad based SPY ETF.
AVTR has a market cap of $5.25 billion. This is considered a Mid Cap stock.
Last quarter Avantor reported $2 billion in Revenue and $.22 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.01.
In the last 3 years, AVTR traded as high as $28.00 and as low as $7.27.
The top ETF exchange traded funds that AVTR belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
AVTR has underperformed the market in the last year with a return of -52.1%, while the SPY ETF gained +18.5%. In the last 3 month period, AVTR fell short of the market, returning -32.2%, while SPY returned -3.6%. However, in the most recent 2 weeks AVTR has outperformed the stock market by returning -0.4%, while SPY returned -2.1%.
AVTR support price is $7.59 and resistance is $8.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVTR shares will trade within this expected range on the day.